Sacral Neuromodulation and Refractory Overactive Bladder: an Emerging Tool for an Old Problem

Overview

Journal Ther Adv Urol

Publisher Sage Publications

Date 2012 Aug 2

PMID 22852028

Citations 5

Authors

Mai Ahmed Banakhar

Tariq Al-Shaiji

Magdy Hassouna

Affiliations

Soon will be listed here.

Abstract

Overactive bladder (OAB) syndrome negatively affects the daily life of many people. Conservative treatments, such as antimuscarinics, do not always lead to sufficient improvement of the complaints and are often associated with considerable side effects resulting in treatment failure. In the case of failure or intolerable side effects, sacral neuromodulation (SNM) and botulinum toxin intravesical injections are minimally invasive and reversible alternatives. Currently, both SNM and botulinum toxin injection have FDA approval for use in OAB patients. This mini-review attempts to provide an update on SNM as a second-line management of adults with refractory OAB, based on the available clinical evidence concerning the efficacy and safety.

Citing Articles

Sacral neuromodulation for neurological disease-induced lower urinary tract symptoms in Saudi Arabia: a single-centre experience.

Banakhar M J Int Med Res. 2022; 50(8):3000605221117221.

PMID: 36039601 PMC: 9434672. DOI: 10.1177/03000605221117221.

Sacral Neuromodulation for Lower Urinary Tract Symptoms: Effect of Therapy on Saudi Patient Sexual Function.

Banakhar M, Youness A Sex Med. 2021; 9(4):100388.

PMID: 34274824 PMC: 8360934. DOI: 10.1016/j.esxm.2021.100388.

Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis.

Lo C, Wu M, Yang S, Jaw F, Chang S Toxins (Basel). 2020; 12(2).

PMID: 32085542 PMC: 7077313. DOI: 10.3390/toxins12020128.

Percutaneous Nerve Evaluation Test Versus Staged Test Trials for Sacral Neuromodulation: Sensitivity, Specificity, and Predictive Values of Each Technique.

Banakhar M, Hassouna M Int Neurourol J. 2016; 20(3):250-254.

PMID: 27706006 PMC: 5083824. DOI: 10.5213/inj.1630498.249.

Effect of sacral neuromodulation on female sexual function and quality of life: Are they correlated?.

Banakhar M, Gazwani Y, Kelini M, Al-Shaiji T, Hassouna M Can Urol Assoc J. 2014; 8(11-12):E762-7.

PMID: 25485001 PMC: 4250238. DOI: 10.5489/cuaj.2300.

References

Foster Sr R, Anoia E, Webster G, Amundsen C . In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn. 2006; 26(2):213-7. DOI: 10.1002/nau.20330. View

Scheepens W, van Koeveringe G, de Bie R, Weil E, Van Kerrebroeck P . Urodynamic results of sacral neuromodulation correlate with subjective improvement in patients with an overactive bladder. Eur Urol. 2003; 43(3):282-7. DOI: 10.1016/s0302-2838(03)00010-1. View

Sutherland S, Lavers A, Carlson A, Holtz C, Kesha J, Siegel S . Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience. Neurourol Urodyn. 2006; 26(1):19-28. DOI: 10.1002/nau.20345. View

Zvara P, Sahi S, Hassouna M . An animal model for the neuromodulation of neurogenic bladder dysfunction. Br J Urol. 1998; 82(2):267-71. DOI: 10.1046/j.1464-410x.1998.00676.x. View

Tai C, Wang J, Wang X, de Groat W, Roppolo J . Bladder inhibition or voiding induced by pudendal nerve stimulation in chronic spinal cord injured cats. Neurourol Urodyn. 2007; 26(4):570-577. DOI: 10.1002/nau.20374. View

Weil E, Ruiz-Cerda J, Eerdmans P, JANKNEGT R, Bemelmans B, Van Kerrebroeck P . Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Eur Urol. 2000; 37(2):161-71. DOI: 10.1159/000020134. View

Deng D, Gulati M, Rutman M, Raz S, Rodriguez L . Failure of sacral nerve stimulation due to migration of tined lead. J Urol. 2006; 175(6):2182-5. DOI: 10.1016/S0022-5347(06)00318-1. View

Tai C, Booth A, de Groat W, Roppolo J . Bladder and urethral sphincter responses evoked by microstimulation of S2 sacral spinal cord in spinal cord intact and chronic spinal cord injured cats. Exp Neurol. 2004; 190(1):171-83. DOI: 10.1016/j.expneurol.2004.07.001. View

Milsom I, Abrams P, Cardozo L, Roberts R, Thuroff J, Wein A . How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001; 87(9):760-6. DOI: 10.1046/j.1464-410x.2001.02228.x. View

10.

Stewart W, Van Rooyen J, Cundiff G, Abrams P, Herzog A, Corey R . Prevalence and burden of overactive bladder in the United States. World J Urol. 2003; 20(6):327-36. DOI: 10.1007/s00345-002-0301-4. View

11.

Borawski K, Foster R, Webster G, Amundsen C . Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women. Neurourol Urodyn. 2006; 26(1):14-8. DOI: 10.1002/nau.20332. View

12.

Peters K, Carey J, Konstandt D . Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14(4):223-8. DOI: 10.1007/s00192-003-1070-3. View

13.

van Kerrebroeck P, van Voskuilen A, Heesakkers J, Lycklama a Nijholt A, Siegel S, Jonas U . Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007; 178(5):2029-34. DOI: 10.1016/j.juro.2007.07.032. View

14.

Kessler T, Buchser E, Meyer S, Engeler D, Al-Khodairy A, Bersch U . Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland. Eur Urol. 2006; 51(5):1357-63. DOI: 10.1016/j.eururo.2006.11.011. View

15.

Temml C, Heidler S, Ponholzer A, Madersbacher S . Prevalence of the overactive bladder syndrome by applying the International Continence Society definition. Eur Urol. 2005; 48(4):622-7. DOI: 10.1016/j.eururo.2005.04.026. View

16.

Schmid D, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M . Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol. 2006; 176(1):177-85. DOI: 10.1016/S0022-5347(06)00590-8. View

17.

Kessler T, Madersbacher H, Kiss G . Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?. Eur Urol. 2005; 47(5):660-5. DOI: 10.1016/j.eururo.2004.11.005. View

18.

Fall M, Lindstrom S . Electrical stimulation. A physiologic approach to the treatment of urinary incontinence. Urol Clin North Am. 1991; 18(2):393-407. View

19.

Everaert K, Kerckhaert W, Caluwaerts H, Audenaert M, Vereecke H, De Cuypere G . A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. Eur Urol. 2004; 45(5):649-54. DOI: 10.1016/j.eururo.2003.11.015. View

20.

Al-Shaiji T, Banakhar M, Hassouna M . Pelvic electrical neuromodulation for the treatment of overactive bladder symptoms. Adv Urol. 2011; 2011:757454. PMC: 3113365. DOI: 10.1155/2011/757454. View